Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Afshin Dowlati

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Clinical Lung Cancer|September 3, 2011
Ongoing trials with bevacizumab and other antiangiogenic agents in lung cancerAfshin Dowlati
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Hunting and trapping the vascular endothelial growth factorAfshin Dowlati
Clinical Advances in Hematology & Oncology : H&O|November 26, 2009
Controversies in multi-institutional phase I clinical trialsAfshin Dowlati
Cancer|June 26, 2020
Slicing and dicing small cell lung cancer to improve trial outcomesAsrar AlAhmadi, Afshin Dowlati
Lung Cancer (Amsterdam, Netherlands)|October 21, 2003
Combination chemotherapy with topotecan for non-small cell lung cancerAfshin Dowlati, Nathan Levitan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2008
Is response rate relevant to the phase II trial design of targeted agents?Afshin Dowlati, Pingfu Fu
Translational Lung Cancer Research|November 19, 2019
Immunotherapy in EGFR mutant non-small cell lung cancer: when, who and how?Debora Bruno, Afshin Dowlati
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2021
Pursuing Immunotherapeutic Targets in SCLCAfshin Dowlati, Timothy Chan
Translational Lung Cancer Research|September 28, 2016
Genomic alterations in small cell lung cancer and their clinical relevanceGary Wildey, Afshin Dowlati
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2014
Defining subgroups of small-cell lung cancerAfshin Dowlati, Gary Wildey
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Clinical Lung Cancer|September 3, 2011
Ongoing trials with bevacizumab and other antiangiogenic agents in lung cancerAfshin Dowlati
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Hunting and trapping the vascular endothelial growth factorAfshin Dowlati
Clinical Advances in Hematology & Oncology : H&O|November 26, 2009
Controversies in multi-institutional phase I clinical trialsAfshin Dowlati
Cancer|June 26, 2020
Slicing and dicing small cell lung cancer to improve trial outcomesAsrar AlAhmadi, Afshin Dowlati
Lung Cancer (Amsterdam, Netherlands)|October 21, 2003
Combination chemotherapy with topotecan for non-small cell lung cancerAfshin Dowlati, Nathan Levitan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2008
Is response rate relevant to the phase II trial design of targeted agents?Afshin Dowlati, Pingfu Fu
Translational Lung Cancer Research|November 19, 2019
Immunotherapy in EGFR mutant non-small cell lung cancer: when, who and how?Debora Bruno, Afshin Dowlati
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2021
Pursuing Immunotherapeutic Targets in SCLCAfshin Dowlati, Timothy Chan
Translational Lung Cancer Research|September 28, 2016
Genomic alterations in small cell lung cancer and their clinical relevanceGary Wildey, Afshin Dowlati
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2014
Defining subgroups of small-cell lung cancerAfshin Dowlati, Gary Wildey
Pageof 23